Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
Institute of HIV Research and Innovation Foundation, Thailand
76 participants
Feb 17, 2025
OBSERVATIONAL
Conditions
Summary
This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on understanding harms, contexts, and needs to develop a tailored intervention.
Eligibility
Inclusion Criteria7
- MSM aged ≥18 years
- Able to communicate in Thai
- Specific by group:
- Chemsex hosts: hosted ≥2 times in past 6 months
- Chemsex guests: attended ≥2 times in past 6 months
- CSO / hospital / police staff: working ≥3 months in related roles
- Provide informed consent
Exclusion Criteria1
- Unable to provide informed consent (e.g., under substance influence at consent)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants (chemsex party hosts and guests) will complete structured self-administered questionnaires to assess: * Substance use patterns and related harms * Sexual health risks (e.g., condom use, HIV/STI testing, PrEP/ART adherence) * Mental health status using validated tools: * Patient Health Questionnaire-9 (PHQ-9) * Generalized Anxiety Disorder-7 (GAD-7) * Socio-legal harms including stigma and discrimination
All stakeholders will participate in semi-structured in-depth interviews: * Exploration phase: guided by EPIS framework * Preparation phase: guided by * Theoretical Domains Framework (TDF) (hosts \& guests) * Consolidated Framework for Implementation Research (CFIR) (organizational stakeholders) The interviews aim to: * Identify harms associated with chemsex * Explore current practices and contexts * Identify barriers and facilitators * Inform development and refinement of a harm reduction model
A novel four-pronged harm reduction model will be developed and refined based on quantitative and qualitative findings. Domains include: * Substance use harm reduction * Sexual health harm reduction * Mental health harm reduction * Socio-legal harm reduction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07512869